1718. Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: an indirect cohort study

BACKGROUND: The 13-valent pneumococcal conjugate vaccine (PCV13) was introduced for infant use in the United States in 2010, replacing PCV7. A U.S. case-control study (2010–2014) demonstrated vaccine effectiveness (VE) for ≥1 dose of PCV13 at 86%; however, this study lacked statistical power to exam...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrejko, Kristin, Gierke, Ryan, Rowlands, Jemma, Rosen, Jennifer, Thomas, Ann, Landis, Zachary, Rosales, Maria, Petit, Susan, Schaffner, William, Holtzman, Corinne, Farley, Monica M, Barnes, Meghan, Harrison, Lee, McGee, Lesley, Chochua, Sopio, Verani, Jennifer, Cohen, Adam, Pilishvili, Tamara, Kobyashi, Miwako
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677475/
http://dx.doi.org/10.1093/ofid/ofad500.1550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677475/
http://dx.doi.org/10.1093/ofid/ofad500.1550

Ejemplares similares